Quantum computing represents the next frontier in computational power. Once developed, these systems could solve complex problems in drug development, financial modeling, and artificial intelligence (AI) that lie beyond the reach of today’s fastest supercomputers.
This revolutionary potential explains why the global quantum computing market is projected to reach $65 billion by 2030 and surge to $850 billion by 2040, according to Boston Consulting Group. As the technology moves from research labs toward commercial adoption, one pioneer has emerged as a frontrunner for investors seeking exposure to this computing revolution.
Image Source: Getty Images.
Let’s dive into the company’s core value proposition to explore why it stands out as one of the best quantum computing stocks to buy now.
Commercial leadership through cloud accessibility
IonQ (IONQ 7.89%) has achieved a significant milestone: quantum hardware is now available across all major cloud platforms. This strategic positioning gives developers and enterprises direct access to quantum computing resources through Amazon Web Services, Microsoft Azure, and Alphabet‘s Google Cloud.
The broad cloud accessibility has driven strong market adoption, with revenue growing 102% year over year in Q3 2024. The availability of IonQ’s quantum systems through major platforms has made it the leading choice for businesses ready to experiment with quantum applications.
Institutional validation fuels growth
Major technology and aerospace leaders have placed significant bets on IonQ’s success. Amazon and Lockheed Martin stand out as key strategic investors, bringing not just capital but valuable industry partnerships to accelerate the commercial adoption of quantum computing technology.
Beyond these strategic partners, institutional investors hold 40.5% of IonQ’s float, an unusually high figure for an emerging technology company. This strong backing probably stems from IonQ’s competitive advantage in intellectual property, including exclusive licenses for core quantum computing technology that create high barriers to entry.
Strategic partnerships drive market expansion
IonQ’s recent collaboration with AstraZeneca marks a significant advancement toward practical quantum computing applications in drug discovery. The landmark partnership will establish a quantum application development center in Sweden, focusing on accelerating pharmaceutical research and development.
The company has also partnered with Ansys to integrate quantum computing capabilities into computer-aided engineering, targeting a $10 billion market. These strategic relationships highlight the growing commercial applications for quantum computing technology across diverse industries.
Government contracts cement the market position
The U.S. Air Force Research Lab recently awarded IonQ a $54.5 million contract to develop scalable and deployable quantum systems. This agreement represents the largest U.S. quantum computing contract awarded in 2024, according to the company.
This four-year contract will help IonQ develop quantum networking technology compatible with existing telecommunications infrastructure. The focus on networking compatibility advances the company’s broader vision of creating interconnected quantum computers for practical applications, a critical step toward quantum computing at scale.
The investing takeaway
As of Dec. 24, IonQ’s shares have jumped by a staggering 259% in 2024. This sharp rise reflects the quantum computing revolution moving from theory to reality. While the company’s $9.65 billion market cap might give some investors pause in light of its meager $83.4 million in projected 2025 sales, its expanding partnerships, government contracts, and cloud platform dominance suggest this could be just the beginning of a much larger growth story.
That said, investors should note that widespread quantum computing adoption requires significant technological advancement and patience. After all, developing fault-tolerant systems capable of running complex commercial applications remains years away.
Still, investors seeking exposure to this emerging technology have a surfeit of options. For instance, the Defiance Quantum ETF, with IonQ as its top holding at 5.93% of assets, offers a diversified approach to this advanced computing theme without the risk associated with individual stocks.
But for those convinced of quantum computing’s future, IonQ’s pure-play status and market leadership make it a compelling choice to capture the full potential of this revolutionary technology.
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. George Budwell has positions in IonQ, Lockheed Martin, and Microsoft. The Motley Fool has positions in and recommends Alphabet, Amazon, and Microsoft. The Motley Fool recommends Ansys, AstraZeneca Plc, and Lockheed Martin and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Add Comment